Patent ID: 7723332

Claim:
A compound of the structure: wherein: R 1 and R 2 are independently selected from the group consisting of H, C 1 to C 6 alkyl, substituted C 1 to C 6 alkyl, C 3 to C 8 cycloalkyl, substituted C 3 to C 8 cycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, C 3 to C 6 alkenyl, C 3 to C 6 substituted alkenyl, C 3 to C 6 alkynyl, substituted C 3 to C 6 alkynyl, —(CH m X n ) z CH p X q , O—C 1 to C 6 alkyl, O—C 1 to C 6 substituted alkyl, and O—(CH m X n ) z CH p X q ; or R 1 and R 2 may be taken together to form a ring of 4 to 8 ring atoms containing in its backbone carbon atoms and 1 to 4 N, O, S, or SO 2 , and where any C-atom or N-atom of said ring is optionally substituted with C 1 to C 4 alkyl, F, or CF 3 ; R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of H, halogen, CN, C 1 to C 6 alkyl, substituted C 1 to C 6 alkyl, —(CH m X n ) z CH p X q , C 3 to C 6 cycloalkyl, substituted C 3 to C 6 cycloalkyl, O—C 1 to C 6 alkyl, O—C 1 to C 6 substituted alkyl, OH, NH 2 , NH—(CH m X n ) z CH p X q , O—(CH m X n ) z CH p X q , N—{(CH m X n ) z CH p X q } 2 , aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, and substituted heterocycle; X is halogen; m and n are, independently, 0 to 2, provided that m+n=2; p and q are, independently, 0 to 3, provided that p+q=3; z is 0 to 10; R 7 is selected from the group consisting of H, C 1 to C 6 alkyl, substituted C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, and substituted C 3 to C 6 cycloalkyl; or a pharmaceutically acceptable salt or tautomer thereof.